{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:43:48Z","timestamp":1782953028753,"version":"3.54.5"},"reference-count":17,"publisher":"S. Karger AG","issue":"2","license":[{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T00:00:00Z","timestamp":1565222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Case Rep Oncol"],"abstract":"<jats:p>Merkel cell carcinoma is a rare but aggressive skin cancer. Response to chemotherapy is not durable but avelumab, an anti-PD-L1 inhibitor, showed promising ongoing response in a phase II trial. Checkpoint inhibitors including avelumab are known to cause overactivation of the immune system, leading to immune-related adverse events (irAE). We describe the first reported case of hypercalcaemia secondary to reactivation of sarcoidosis in a patient with metastatic Merkel cell carcinoma on avelumab. Hypercalcaemia was managed with corticosteroids to full resolution and avelumab therapy was safely continued.<\/jats:p>","DOI":"10.1159\/000502285","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T21:00:32Z","timestamp":1565298032000},"page":"639-643","source":"Crossref","is-referenced-by-count":13,"title":["Hypercalcaemia due to Sarcoidosis during Treatment with Avelumab for Metastatic Merkel Cell Carcinoma"],"prefix":"10.1159","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0326-1591","authenticated-orcid":false,"given":"Sandy","family":"Tun\u00a0Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina\u00a0I.C.","family":"Nordman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huy\u00a0A.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2019,8,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djq120"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2014.124"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.815"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30364-3"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-017-0310-x"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00107912"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw125"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2015.10.082"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/1078155216667635"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14808"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0000000000000181"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra071714"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.10"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2017.11.030"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201401-0188OC"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-015-9826-3"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2006.06.025"}],"container-title":["Case Reports in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/502285","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/502285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T15:50:10Z","timestamp":1745423410000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000502285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,8]]},"references-count":17,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,9,4]]}},"URL":"https:\/\/doi.org\/10.1159\/000502285","archive":["Portico"],"relation":{},"ISSN":["1662-6575"],"issn-type":[{"value":"1662-6575","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,8]]}}}